Where does Biocon Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biocon Ltd. ranks #6,419 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biocon Ltd. hold?

Biocon Ltd. holds 52 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Biocon Ltd.'s Innovation Score?

Biocon Ltd. has an Innovation Score of 37.7 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biocon Ltd. focus on?

Biocon Ltd.'s top technology area is C07K (Peptides) with 34 patents, ranking #284 of 3,615 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is Biocon Ltd.'s patent grant rate increasing or decreasing?

Biocon Ltd.'s recent grant velocity is -35% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biocon Ltd.'s patents?

Biocon Ltd.'s patents average 9.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biocon Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biocon Ltd.

USPTO PatentsView assignee record - 52 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biocon ranks #6,419 of 49,997 tracked US assignees by granted-patent volume, with 52 patents across 18 technology areas.

#6,419
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 9.5
avg claims per patent: -35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6419 · Foreign Corporation #6,419 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 52 grants
UPPER-Q #6,419/49,997
PHOTO-FINISH Barnett Outdoors
CPC-FOCUS C07K · 18 areas
INNOV-THIN 37.7/100
CLAIMS-PAR 9.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -35% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Barnett Outdoors, LLC. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biocon’s 37.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.7 pts (36%) Velocity 3.3 pts (9%) Breadth 15.0 pts (40%) Claim depth 5.7 pts (15%)

Qualcomm Incorporated · highest

85
Biocon · this assignee

38
Hebe Studio · near

38
SK Hynix Memory… · near

38
Sony Computer… · near

38
Wellfine Silicone… · near

38
3D Lighting… · lowest

7

What this shows Biocon's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biocon?

Each dot is one of Biocon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biocon’s own 9.5 claims/patent is at or below the 12.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biocon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biocon's grants concentrate

Biocon Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 65.4% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (10 grants) versus a trough of 1 in 2023. By volume, Biocon sits between Barnett Outdoors, LLC. and Cosmo OIL Co., Ltd..

Biocon's three-year grant acceleration

Biocon Ltd. shows 8 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Barnett Outdoors

52
Behr-hella Thermo…

52
BSN Medical

52
Bettcher Industri…

52
Cameron Solutions

52
Chyng Hong

52
Convatec

52
Cosmo OIL

52
Biocon ◀

52

What this shows Biocon holds 52 patents at rank #6,420, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biocon

By rank, the assignees closest to #6,420 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Biocon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biocon, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Biocon ranks #284 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Sony Computer Entertainment Europe Ltd. 38 SK Hynix Memory Solutions Inc. 38 Hebe Studio Limited 38 Wellfine Silicone Products Co., Ltd. 38

Similar claim depth

Nearest assignees by average claims per patent (9.5 here).

Humanscale Corporation 9.5 avg Grand Mate Co., Ltd. 9.5 avg Inventec (PUDONG) Technology Corporation 9.5 avg Eugene Technology Co., Ltd. 9.5 avg

Biocon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biocon Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	15.4%
2016	6	11.5%
2017	7	13.5%
2018	6	11.5%
2019	4	7.7%
2020	2	3.8%
2021	10	19.2%
2022	4	7.7%
2023	1	1.9%
2024	3	5.8%
2025partial year	1	1.9%

Which technologies does Biocon Ltd. patent most?

C07K - Peptides 34

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 33

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 15

C07D - Heterocyclic Compounds 12

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 10

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 6

C07C - Acyclic OR Carbocyclic Compounds 4

C12Y - Enzymes 3

B01D - Separation 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biocon Ltd.'s patent record in context - here's where to go next.

Biocon Ltd.'s lead technology class is C07K (Peptides), 65.4% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #6,419 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biocon Ltd. against Barnett Outdoors, LLC., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.